chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021 at 10:55 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 81.66 years. No concomitant product use was reported. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Vial was stored on cooler 1, on 07-Jan-2021, Excursion duration at 9 am: 34, at 10 am 34, at 11 am 36, at 12 am 37, at 1 pm 38, at 2 pm 38, at 3 pm 40, at 4 pm 40.  On 07-Jan-2021, excursion time and temperature at 09, 10 am was 34, 34 respectively, total doses given for the day was 96, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 05-Jan-2021, vial was moved to clinic on 07-Jan-2021. 6 vial was moved to clinic. Vaccine BUD date was 27-Jan-2021.  Temperature recordings were taken by using a  traceable temperature monitor at every hour. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided
Pt described a difficulty swallowing, slight swelling, and a brief time of altered mental status about 30 minutes after vaccine administration. Pt was able to calm down and described a slight alleviation in symptoms. Pt denied hx of anaphylaxis. Medics were dispatched to the location to transport. No medications given by health department or EMS on scene.
All of my Fibro and Arthitis symtoms were heightened 10 fold.  This lasted for about 3 days - was unable to do much of anything - pain level was about 9 to 10 for those days.  Also had a headache too.
patient reported itchy hives from the neck down. She has taken benadryl and it has relieved her symptoms that she is currently still experiencing. Reports no other issues.
Purpuras in left and right forearms, not tender, not blanching, not raised, not itchy, lasting for 7 days in right arm, left arm pupura still present but smaller size refers mom. No treatment.
fever; chills; body aches during the night/body aches into the next day; This is a spontaneous report from a contactable consumer or other non hcp. A 58-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 03Mar2021 (at the age of 58-year-old) (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not received any other vaccines prior to the COVID vaccine. The patient had not been tested for COVID-19. The patient had no allergies. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unknown date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. On 03Mar2021, after second shot was administered, patient felt fever, chills, and body aches during the night and into the next day. The patient not received treatment for these events. The clinical outcome of the events were recovered on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient tested positive for the coronavirus; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Patient tested positive for the coronavirus) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced COVID-19 (Patient tested positive for the coronavirus). At the time of the report, COVID-19 (Patient tested positive for the coronavirus) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.No treatment information was provided.
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 27-JUN-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally, LOT# R027157, expiry date 14-JUL-2020 for prophylaxis. The vaccine was exposed to a temperature of 34.2 F for 4 hours and 54 minutes. This call was made because of a digital data logger. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674: US-009507513-1907USA000862: US-009507513-1907USA000882: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000898: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1907USA000903:
3/26/2021: 9:30AM: Received Johnson & Johnson COVID-19 vaccine. 8:45PM: Mild headache started 9:30PM: Significant chills, inability to feel warm. 11:00PM: Fell asleep. 3/27/2021: 02:00AM: Woke up with pounding headache, fever of 101, nauseous, chills came in waves.   04:30AM: Vomited. 07:00AM: Chills stopped, fever gone, headache remained.
I am a highly sensitive person.  After the first injection my blood pressure was much higher than normal at a routine physical with my doctor. The second injection caused me to experience extremely elevated anxiety, with heart palpitations, digestive problems, and panic. I've used rest, fluids, ginger tea and sleepy time tea to treat. Now, on day 5, the symptoms have diminished but not disappeared.
Chill, left arm swollen/red-size approximately 10" x 4" patch skin gets hardened. Pain in left arm. Treatment BACTRIM DS #14 one BID. ZYRTEC 10 mg #30 one QD.
itchy bumps in left arm; Red round circle in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (itchy bumps in left arm) and VACCINATION SITE ERYTHEMA (Red round circle in the left arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 941L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (itchy bumps in left arm) and VACCINATION SITE ERYTHEMA (Red round circle in the left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE URTICARIA (itchy bumps in left arm) and VACCINATION SITE ERYTHEMA (Red round circle in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Initial and follow up information has been received from a healthcare professional and a physician, via the Merck pregnancy registry, concerning a 20 year old female patient with no previous pregnancies, with gastrooesophageal reflux disease and papilloma viral infection and a history of anaemia, pneumonia, infectious mononucleosis, ulcer, Papanicolaou smear abnormal and colposcopy, who in May 2007, was vaccinated with the first dose of GARDASIL.  The date of the LMP was approximately 01-May-2007, date of conception estimated as 15-MAY-2007.  On 25-JUN-2007, an ultrasound confirmed the patient to be 8 weeks and 1 day into the pregnancy; the estimated date of delivery was 05-FEB-2008.  Follow-up information was received from the physician's office.  On 06-FEB-2008 the patient delivered a healthy 7 pound 2 ounces baby boy with an Apgar score of 8/9.  The patient was 40 weeks from LMP.  The patient was Group B streptococcus positive (GBS+).  From 19-DEC-2007 to 22-JAN-2008 fetal activity both reactive was monitored for decreased fetal motion.  Additional information is not expected.
Systemic: Vomiting-Mild, Additional Details: Pt was a little nervous for vaccine, but was hydrated and no problem with previous vaccine.  Pt was fine after vaccination, but about 5 to 10 min after vaccine she threw up.  Gave her water, wet paper towels to cool down, candy. Took her pulse- was normal. She felt better. kept her additional 15 min. She was fine  then. Called her later in afternoon, and she said she was good.
10 cm erythematous, non tender, swelling right antero-lateral thigh reacted 12 hour after shot BENADRYL treatment orally.
Narrative:  COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/08, Pfizer, dose #2 08/15 pt cc: chills, fatigue, fever, headache, loss of taste or smell, myalgias exposure: unknown 0813 COVID swab, result: detected 08/13 SARS-COV-2 LINEAGE result: B.1.617.2 08/13 SARS-COV-2 CLADE result: 21A 08/21 clinically resolved
Immediately after shot - light headed, nausea, high blood pressure - treated (monitored) by paramedic at vaccine clinic and sent home; 3 hours later - swelling on the left side of face - treated at my physicians office
Patient said she woke up in the night of 3/22/19 and ached from her neck to her toes, even her elbows. She felt chilled and felt like she needed more clothes on. She said Friday, 3/22/19 was a bad day, she didn't do much of anything. Saturday, 3/23/19 she felt better but still not right. She had redness at injection site and it is still sore today, 3/25/19 when I spoke to her on the phone.
The flu shot was administered in the afternoon. During the night, she developed chest pain. It last for a couple of hours. Her right arm was very hot and swollen. She could not make  a fist due to the swelling in that arm, 9 days later, the arm was still warm to touch. Two days after receiving the vaccine she developed diarrhea, cold symptoms and runny nose. This lasted for a number of days. She felt as though she had the flu.
Menactra vaccine administered on 6/15/2005 at ~10:30 am.  On 6/16/2005 at 7:00 am, patient's father contacted MD to report that patient had a cough, fever of 102.6F, sore arm, and headache.  Patient was monitored at home by family per MD. Given Tylenol and Advil for fever and arm pain.  On 6/17/2005 8:00am, MD contacted patient's father and patient is afebrile, denies headache and sleeping comfortably.
Patient did not actually faint but said she gets nervous about the vaccines and after giving the vaccine saw her with  her hands on her neck so went to check on her and she said she feels she may faint and when asked if she wants to lay down she said that would be fine. Had her elevate the legs and gave her a cold pack and kept observing her. She said she is feeling okay as she is laying down. She laid down for almost 35-40 minutes and then said she wants to sit . Sat for another 20 min while a tech sat by her and then left after we made sure she was doing okay. She called and said she is doing fine after she reached her  office.
Patient presented to clinic for Pfizer dose #2. Stated that she had high BP after first dose done on 3/25/2021 and after it read over 200 systolic and was given nitroglycerin and sent to emergency room. Patient repeated history within 1 hour after second dose. Second dose given at 8:38am. By 9:20am patient stated feeling dizzy and bp was 154/65 with pulse of 56. By 9:30am patient stated headache in addition to dizziness and BP up to 171/64. At 9:48am BP 181/69, Pulse 56 and patient stated worsening dizziness and headache. Transport called to assistance to ED. At 10:29am BP 202/67 and given 1 dose of oral hydralazine.
Bump on elbow; bump on elbow, half size of golf ball; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 immunization.     Concurrent medical conditions included Lung disease. Concomitant products included OXYGEN for Supplementation therapy.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling). At the time of the report, JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling) outcome was unknown.            The patient stated that he uses more supplemental oxygen.  Treatment medication information was not provided.
I have I inflammation and pain in that arm; I have I inflammation and pain in that arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Jan2022 as dose 3 (booster), single (Lot number: FJ1614) at the age of 44 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (Vaccine brand: Pfizer/BioNTech, Vaccine administration date: 20Apr2021, Vaccine lot number: EW0170, Vaccine dose number: 1, Vaccine location: Left arm), administration date: 20Apr2021, when the patient was 44-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 2, Treatment start date: 12May2021, Lot number: EW0167), administration date: 12May2021, when the patient was 44-year-old, for COVID-19 Immunization, reaction(s): "Extreme pain in left breast and left arm", "Extreme pain in left breast and left arm", "I had Inflammation". The following information was reported: PAIN IN EXTREMITY (disability), INFLAMMATION (disability), outcome "not recovered" and all described as "I have inflammation and pain in that arm". Therapeutic measures were taken as a result of pain in extremity, inflammation. Additional information: No Other medication in 2weeks. Ae treatment included Steroid shot. The reporter reported that she had Extreme pain in left breast and left arm. Went to Dr. and they confirmed she had Inflammation. She got the booster in right arm and now she has inflammation and pain in that arm. This was over a year and still in extreme pain. No known allergies. No Other medical history.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201374946 Same reporter/patient, same drug/different dose, same AEs;
Pt c/o felt nausea, sweaty, ears became tingling and then went number. Was in placed in a wheelchair and assisted to private location. C/o eyes feeling funny and tearing. next c/o chest pressure and tingling started down legs. Breathing labored and flushed skin. Epi administered and assisted to ER.
RASH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced rash. On 05-APR-2021, Laboratory data included: Blood test (NR: not provided) no antibodies. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rash was not reported. This report was non-serious.
fever of 100.0 cough/chills/body aches  Exposure to COVID-19 virus
On 01/20/2021-12 hours after the vaccination, in the middle of the night I woke up with chills, my teeth chattering, I was running a fever, I went to take a shower, and my body just ached really bad. The diarrhea started 2 days after the shot, I took the antidiarrhea medicine. I was out of work on Wednesday and Thursday. After 2 days I got it under control.
Breast were swollen; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown, Expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced breast were swollen on an unspecified date. The patient wanted to know if second shot can be taken when breast were swollen. The outcome of event was unknown.   Follow-up attempts are completed. No further information is expected.
2 weeks after 1st dose of covid vaccine,  some fatigue and sob. The next morning, sudden onset of sob, chest pain.  To Emergency department,  cath lab, stent. Home within 36 hrs.
This spontaneous report as received from a physician via a field employee refers to a patient of unknown age and gender. On an unspecified date in 2014, the patient was vaccinated with a dose of PNEUMOVAX23 (lot #, dose, route and indication not reported). Other suspect therapies included ZOSTAVAX (lot #, expiration, dose and route not reported) on an unspecified. The patient sought medical attention at physician's office on an unspecified date and complained of a red, swollen area between the shoulder and elbow in the arm where ZOSTAVAX was administered. The outcome of the event was unknown. Additional information is not expected.
Lateral epicondylitis - severe right elbow pain with referred pain into thumb/forefinger. Nerve inflammation through forearm/right shoulder/between scapula and into left forearm/shoulder also but much milder than right side.
Follow up report to the original report: Cognitive difficulties, like naming things, people, plants and even my horses and dogs (stuff you don't forget). Not as cognitively sharp. I am use to being pretty smart. It's hard to remember important things. The neurologist says there is nothing really to do. No treatment at this time.
Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: has shortness of breath, weakness, and inflammation of the body
Nausea began 10 1/2 hours after receiving vaccine; 24 hours after vaccine - vomiting, diarrhea, headache and right side flank pain.
Previous Vaers entered for patients 2nd dose administered in the ventrogluteal site. Chart review reflects patient also received first dose via ventrogluteal muscle versus the deltoid muscle. Patient reported no side effects from first vaccine.